Hipragumboro-GM97 or. susp. (lyoph.) vial

Country: Belgium

Language: English

Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Active ingredient:

Infectious Bursal Disease Virus (live)

Available from:

Laboratorios Hipra S.A.

ATC code:

QI01AD09

INN (International Name):

Gumboro Virus (IBDV)

Pharmaceutical form:

Lyophilisate for oral suspension

Composition:

Gumboro Virus (IBDV)

Administration route:

Oral use

Therapeutic group:

poultry

Therapeutic area:

Avian Infectious Bursal Disease Virus (Gumboro Disease)

Product summary:

CTI code: 267005-02 - Pack size: 5000 doses - Commercialisation status: NO - CNK code: 2214930 - Delivery mode: Medical prescription; CTI code: 267005-01 - Pack size: 1000 doses - Commercialisation status: NO - CNK code: 2214922 - Delivery mode: Medical prescription; CTI code: 267005-04 - Pack size: 10 x 5000 doses - Commercialisation status: YES - CNK code: 2214930 - Delivery mode: Medical prescription; CTI code: 267005-03 - Pack size: 10 x 1000 doses - Commercialisation status: NO - CNK code: 2937357 - Delivery mode: Medical prescription

Authorization status:

Commercialised: Yes

Authorization date:

2004-09-13